Celldex Therapeutics

IPO

Pioneering new horizons in immunology

Public · HAMPTON, United States · Founded 1983 · $300.0M raised

Employees
51–200
Founded
1983
Business Model
B2B
Total Funding
$300.0M
Last Round
$300.0M Venture RoundMar 2024
Rounds
1
Type
Public

About

Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering novel antibody-based treatments that engage the human immune system to improve the lives of patients with allergic, inflammatory, and autoimmune disorders. Originally founded in 1983 as AVANT Immunotherapeutics and renamed Celldex Therapeutics in 2008 following a merger with private Celldex Therapeutics Inc., the company is headquartered in Hampton, New Jersey. Celldex focuses on advancing mast cell biology and developing therapeutic antibodies targeting conditions such as urticaria, atopic dermatitis, and other immunological diseases. The company is publicly traded on Nasdaq under the ticker symbol CLDX.

Summary

Celldex Therapeutics is a Biotech company based in HAMPTON, United States, founded in 1983. It has raised $300.0M in total across 1 round, most recently a $300.0M Venture Round in Mar 2024.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundMar 2024
$300.0M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Celldex Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/celldex-therapeutics"><img src="https://indexed.vc/api/badge/company/celldex-therapeutics" alt="Celldex Therapeutics on Indexed.vc" width="260" height="76" /></a>